Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Everestbakeron May 08, 2023 8:56pm
66 Views
Post# 35437636

RE:RE:RE:RE:RE:RE:Simple fact

RE:RE:RE:RE:RE:RE:Simple fact

Ciao wrote:
prophetoffactz wrote:

"provide Strawman arguments while promoting the status quo"
 

I'm saying that the next set of key catalysts are financed, 100% owned by CZO, and the path to them has been set in motion from Health Canada approval for the avenanthramide trial, to PGX scale-up leading to a potential deal, to the fibrosis trial which has a 'go / no go' decision this summer. 

Why don't you provide a valuation of these assets upon successful completion of these defining and strategic catalysts. That is the gold. 



There's only one poster here that continues to provide Strawman arguments while promoting the status quo and the can do no wrong management team as stellar performance both in corporate developments and shareholder value. 

 

Amen Ciao. I'm speechless at how much time the poster has to defend the staus quo. We all have our own small business to run or a regular job (maybe this is their job) See you all at the AGM. 

<< Previous
Bullboard Posts
Next >>